A phase II study of radical surgery followed by postoperative chemotherapy with S-1 for gastric carcinoma with free cancer cells in the peritoneal cavity (CCOG0301 study)
- 30 November 2009
- journal article
- Published by Elsevier BV in European Journal of Surgical Oncology
- Vol. 35 (11), 1158-1163
- https://doi.org/10.1016/j.ejso.2009.03.003
Abstract
No abstract availableKeywords
This publication has 23 references indexed in Scilit:
- S-1 plus cisplatin versus S-1 alone for first-line treatment of advanced gastric cancer (SPIRITS trial): a phase III trialThe Lancet Oncology, 2008
- Adjuvant Chemotherapy for Gastric Cancer with S-1, an Oral FluoropyrimidineNew England Journal of Medicine, 2007
- Clinical Outcomes With Laparoscopic Stage M1, Unresected Gastric AdenocarcinomaAnnals of Surgery, 2006
- Phase I Pharmacokinetic Study of S-1 Plus Cisplatin in Patients With Advanced Gastric CarcinomaJournal of Clinical Oncology, 2005
- The Value of Peritoneal Cytology as a Preoperative Predictor in Patients With Gastric Carcinoma Undergoing a Curative ResectionAnnals of Surgical Oncology, 2005
- Feasibility study of adjuvant chemotherapy with S-1 (TS-1; tegafur, gimeracil, oteracil potassium) for gastric cancerGastric Cancer, 2004
- Randomized Trial of Adjuvant Chemotherapy With Mitomycin, Fluorouracil, and Cytosine Arabinoside Followed by Oral Fluorouracil in Serosa-Negative Gastric Cancer: Japan Clinical Oncology Group 9206–1Journal of Clinical Oncology, 2003
- Postoperative outcome and sites of recurrence in patients following curative resection of gastric cancerBritish Journal of Surgery, 2000
- An Early Phase II Study of Oral S-1, a Newly Developed 5-Fluorouracil Derivative for Advanced and Recurrent Gastrointestinal CancersOncology, 1999
- Late phase II study of novel oral fluoropyrimidine anticancer drug S-1 (1M tegafur–0.4M gimestat–1M otastat potassium) in advanced gastric cancer patientsEuropean Journal Of Cancer, 1998